Clinician-scientist @hkudeptmedicine @hkumed #Gastroenterology #Hepatology
Joined September 2021
- Tweets52
- Following99
- Followers88
- Likes128
Rex Wan-Hin Hui retweeted
The level of small HBs, the most abundant isoform of HBsAg in the blood of individuals with chronic hepatitis B infection, was predictive of HBsAg seroclearance after planned cessation of the nucleoside analogue. @JHEP_Reports @EASLedu @EASLnews @hkumed
jhep-reports.eu/article/S258…
Rex Wan-Hin Hui retweeted
Excellent #GUTAbstract by @RexWHHui on the paper
"Large-scale profile study on hepatitis B surface antigen levels in chronic hepatitis B: implications for drug development targeting functional cure" via bit.ly/3XbGS5c
@hkumed @hkudeptmedicine @WK_Seto @IvanHung2 @loeymak @FrontGastro_BMJ #HBsAg #HepatitisB #CHB
Rex Wan-Hin Hui retweeted
We studied Days At Home (DAH) reflecting the disease time burden. Immunotherapy gives HCC patients more DAH than tyrosine kinase inhibitor treatment. jhep-reports.eu/article/S258…
Congratulations to @RexWHHui @MattChungHKU @CarlosWongHKU @Ian_HKU @hkumed @JHEP_Reports
Rex Wan-Hin Hui retweeted
HKUMed researchers have started clinical trials exploring a pioneering gene-related therapy for chronic hepatitis B infection, potentially allowing patients to stop long-term medication.
For more: hkumed.hk/bbdc5b
ALT The research team, pictured in white coats from right, includes Professor Loey Mak, Professor Yuen Man-fung, Professor Walter Seto Wai-kay, and Dr Rex Hui, alongside Mr Cheung (middle), a patient who has completed his medication.
ALT Professor Yuen Man-fung during the press conference
Rex Wan-Hin Hui retweeted
A new article in Hepatology International examines emerging therapies for HBsAg seroclearance, with a focus on innovative novel combination strategies that hold promise for functional cure. This comprehensive review offers critical insights for clinicians and researchers alike.
🔗 Read the full article here: link.springer.com/article/10…
#Hepatology #HepatitisB #HBsAgSeroclearance #NovelTherapies #CombinationTherapy #MedicalResearch #LiverHealth #HepatologyInternational #HealthcareProfessionals
Rex Wan-Hin Hui retweeted
Our paper described the longitudinal profile of blood levels of HBV pregenomic RNA in CHB 🦠patients treated with long term NUC 💊now in press @CMH_journal
e-cmh.org/m/journal/view.php…
Clinical parameters eg age, gender, PAGE-B score and HBeAg can influence pgRNA levels #mfyuen
Rex Wan-Hin Hui retweeted
Hepatology team from @hkudeptmedicine attending The Liver Meeting @AASLDtweets @AASLDFoundation @WK_Seto @jamesyyfung @RexWHHui
Rex Wan-Hin Hui retweeted
#GUTAbstract by Mao et al on
"Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study" via bit.ly/3Ls3Y1I
Paper: bit.ly/4bSWGyQ
@WK_Seto @CheungKaShingM2 @hkumed @HKUniversity
Rex Wan-Hin Hui retweeted
Our very own associate TAE @RexWHHui and team describe an interesting case of a sub-diaphragmatic air-fluid level 👇
bit.ly/3GaxWEs
@sheiybani @MohsenSubhani @VivekGoodoory @DunnePdj @DrJMKennedy @RMBeattie50
Rex Wan-Hin Hui retweeted
Professor Yuen Man Fung developed an interest in hepatitis B early in his career thanks to the prevalence of the disease in Hong Kong. Almost three decades on, his breakthrough research is now guiding potential treatments.
For more: buff.ly/47gArRJ
Rex Wan-Hin Hui retweeted
Check out two recently published articles on the advances in Hepaititis B and Hepatitis D treatments!
journals.lww.com/cld/fulltex…
journals.lww.com/cld/fulltex…
Rex Wan-Hin Hui retweeted
🆕Article in press❕
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B
Read it here👉journal-of-hepatology.eu/art…
#LiverTwitter
Rex Wan-Hin Hui retweeted
Researchers from HKUMed have launched a pilot programme to provide rapid screening for hepatitis C followed by treatment for people in custody in Stanley Prison.
@loeymak @hkudeptmedicine
For more: hkumed.hk/3ws
Rex Wan-Hin Hui retweeted
A small step in Hong Kong 🇭🇰 for microelimination of hepatitis C infection @hkumed @hkudeptmedicine med.hku.hk/en/news/press/202… – at Central & Western District, Hong Kong
Rex Wan-Hin Hui retweeted
Professor Yuen Man Fung developed an interest in hepatitis B early in his career thanks to the prevalence of the disease in Hong Kong. Almost three decades on, his breakthrough research is now guiding potential treatments.
For more: buff.ly/3s7SuKL
Rex Wan-Hin Hui retweeted
journals.lww.com/ijmr/Citati…
This year's World Hepatitis Day with editorial by @RexWHHui
Rex Wan-Hin Hui retweeted
#HKASLD bimonthly meeting with @RexWHHui @hkumed presenting on novel #HBV and #HDV therapeutics and @clauds_wu @CUHKGI @CUHKMedicine presenting on risk stratification for variceal bleeding in HCC
@jamesyyfung
